PBAM PBAM
Company Profile ↓Company Overview
PBAM (PBAM) is a publicly traded company listed on with a market capitalization of $491.25M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 15.4%, reflecting efficient use of shareholder capital.
Net profit has compounded at 18.1% per year over the last five years.
Revenue has grown at a 13.6% CAGR over the past five years.
Trades at an undemanding P/E of 12.4.
Maintains a net profit margin of 32.5%.
Carries low leverage with a debt-to-equity ratio of 0.11.
Recent Developments
- Dec 2025 Revenue of $125.16M (+17.1% YoY); net profit $40.67M.
- Trailing 12 Months Year-on-year growth — revenue +17.1%, earnings +13.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.6%, profit CAGR 18.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.60% |
| 1 Year: | 17.08% |
Compounded Profit Growth
| 5 Years: | 18.07% |
| 1 Year: | 13.52% |
Stock Price Performance
| 1 Year: | +48.79% |
| 6 Months: | +40.94% |
| 3 Months: | +15.13% |
| 1 Month: | +15.52% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)87.98 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 32.5%.
- Compounding revenue at 13.6% over 5 years.
- Profit CAGR of 18.1% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- RSI at 88 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 29.35M | 29.34M | 31.84M | 32.47M | 34.54M | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| Interest Expense | 13.02M | 12.54M | 11.88M | 10.82M | 9.80M | - |
| Pretax Income | 15.15M | 14.99M | 14.86M | 14.18M | 16.84M | - |
| Tax Provision | 4.49M | 4.43M | 4.41M | 4.22M | 4.82M | - |
| Net Income | 10.66M | 10.56M | 10.45M | 9.95M | 12.03M | - |
| Diluted EPS | - | 1.80 | 1.77 | 1.71 | 2.07 | 2.27 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 85.36M | 95.24M | 106.90M | 125.16M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 6.21M | 35.34M | 54.34M | 47.15M |
| Pretax Income | - | 34.94M | 57.42M | 50.85M | 57.83M |
| Tax Provision | - | 10.23M | 16.56M | 15.02M | 17.17M |
| Net Income | - | 24.71M | 40.86M | 35.82M | 40.67M |
| Diluted EPS | - | 4.33 | 7.11 | 6.15 | 6.92 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.85B | 2.15B | 2.42B | 2.54B |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 136.56M | 182.10M | 168.06M | 159.37M |
| Inventory | - | - | - | - | - |
| Receivables | - | 5.29M | 7.50M | 7.99M | 8.28M |
| Total Liabilities | - | 1.71B | 1.97B | 2.20B | 2.27B |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | 17.95M | 74.96M | 25.97M | 25.98M |
| Total Debt | - | 17.95M | 74.96M | 45.97M | 28.98M |
| Total Equity | - | 143.32M | 185.78M | 223.53M | 263.96M |
| Shares Outstanding | - | 5.60M | 5.72M | 5.77M | 5.73M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 41.17M | 33.52M | 37.73M | 47.20M |
| Investing Cash Flow | - | -379.35M | -241.65M | -281.57M | -122.66M |
| Financing Cash Flow | - | 317.74M | 257.59M | 229.62M | 66.60M |
| Capital Expenditure | - | -364.00K | -835.00K | -1.51M | -1.55M |
| Free Cash Flow | - | 40.80M | 32.69M | 36.22M | 45.64M |
| Net Change in Cash | - | -20.44M | 49.46M | -14.22M | -8.86M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 28.9% | 42.9% | 33.5% | 32.5% |
| ROE % | - | 17.2% | 22.0% | 16.0% | 15.4% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PBAM
Private Bancorp of America, Inc. Announces Uplisting to Nasdaq Global Select Market
LA JOLLA, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Private Bancorp of America, Inc. (NASDAQ: PBAM), (the “Company”), the holding company for CalPrivate Bank (the “Bank”), announced today that its Registration Statement on Form 10 has been …
Here's What Key Metrics Tell Us About Private Bancorp of America (PBAM) Q2 Earnings
While the top- and bottom-line numbers for Private Bancorp of America (PBAM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimate…
Private Bancorp of America, Inc. (PBAM) Tops Q2 Earnings and Revenue Estimates
Private Bancorp of America (PBAM) delivered earnings and revenue surprises of +13.50% and +0.42%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?…
Private Bancorp of America, Inc. Announces Continued Strong Net Income for Second Quarter 2026 and Intent to Uplist to the NASDAQ Stock Market
Second Quarter 2026 Highlights Net income for the second quarter of 2026 was $13.1 million, compared to $12.0 million in the prior quarter and $10.4 million in the second quarter of 2025.Net income for the second quarter of 2026 represents …
CalPrivate Bank Appoints Robert Tidd as General Counsel
LA JOLLA, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Private Bancorp of America, Inc. (OTCQX:PBAM), (the “Company”) and CalPrivate Bank (the “Bank”) today announced that Robert Tidd has joined the Bank as Executive Vice President and General…
CalPrivate Bank Appoints Veteran Credit Executive as Acting Chief Credit Officer
LA JOLLA, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Private Bancorp of America, Inc. (OTCQX:PBAM), (the “Company”) and CalPrivate Bank (the “Bank”) today announced that Andrew Meitzen has resigned from the position of Chief Credit Officer, …
PBAM — Frequently Asked Questions
What is the current share price of PBAM?
As of 2026-08-05 17:25 PDT, PBAM trades at $85.76 on NASDAQ/NYSE. Its 52-week range is $54.99 to $85.76.
What is the market capitalisation of PBAM?
PBAM has a market capitalisation of $491.25M on NASDAQ/NYSE.
What is the P/E ratio of PBAM?
PBAM trades at a trailing price-to-earnings (P/E) ratio of 12.39. Its price-to-book (P/B) ratio is 1.86.
What is the return on equity (ROE) of PBAM?
PBAM has a return on equity (ROE) of 15.41%.
Is PBAM a good stock to buy?
This page provides a data-driven analysis of PBAM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.